Regulation and Products


In 2009, we won a hard-fought campaign that led to Congress passing a law granting the U.S. Food and Drug Administration (FDA) the authority to regulate all tobacco products, including cigarettes, e-cigarettes, cigars and hookah. Yet, it took the FDA seven years to begin their oversight of many of these products with much more work left to be done. 

Recent spikes in the use of e-cigarettes makes clear that more must be done to regulate tobacco products and the industry's deceptive marketing practices.  We are working to ensure the government fully leverages the regulatory power it now possesses to protect children and adults. 

Tobacco use costs our nation nearly $300 billion in health care and productivity losses each year.

Take Action

Big Win Against Big Tobacco

It's time to end the youth e-cigarette vaping epidemic

We need Congress to choose kids and families over Big Tobacco and the e-cigarette industry.

Latest Updates

December 17, 2020

A new survey released today from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) finds overall tobacco use among middle and high school students has declined from 2019-2020. However, cigarette use did not decline.

Cancer Candor Blog
October 2, 2020

Today’s blog is one of a series of posts highlighting how ACS CAN is examining, prioritizing and pursuing policy interventions that ensure everyone has an equal opportunity to prevent, find, treat and survive cancer. Achieving health equity in communities nationwide is a cornerstone of our mission.

September 9, 2020

Today, September 9, is the court-ordered deadline for manufacturers of e-cigarettes and certain other tobacco products to apply to the U.S. Food and Drug Administration to keep their products on the market.

August 21, 2020

WASHINGTON, D.C. – U.S. Department of Health and Human Services (HHS) announced their decision Wednesday to rescind all guidance related to U.S. Food and Drug Administration (FDA) oversight of laboratory developed tests (LDTs), a move that could have broad, negative health consequences. The following is a statement from Lisa Lacasse,

Regulation and Products Resources

American Cancer Society Cancer Action Network, American Academy of Pediatrics, American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, and Truth Initiative present the following principles FDA should use when implementing the premarket review process for tobacco products.

This factsheet provides a summary of the premarket review requirements and status of FDA's enforcement of the requirements.

A comment letter which details why 22nd Century Group's modified risk tobacco product application should be denied by the Food and Drug Administration.